Pharmaceutical Procurement for RAPS Hospital: Losartan, Chlorthalidone, and Essential Medicines Supply

Work Description - NA

This tender invitation, issued by the Nuclear Power Corporation of India Limited under the Department of Atomic Energy, is for the procurement of a comprehensive range of pharmaceuticals, as detailed in the Bill of Quantities (BOQ) titled "TABLET LOSARTAN CHLORTHALIDONE and other medicines." The specified items include Tablet Losartan/Chlorthalidone, Tablet Olanzapine, Liquid Povidone-Iodine, Liquid Chlorhexidine Gluconate/Sodium Fluoride/Zinc Chloride/Cetrimide/Triclosan, Respuels Salbutamol, Inhaler Tiotropium, Respuels Levosalbutamol, Injection Moxifloxacin, Injection Erythropoietin, Cream Silversulphadiazine, and Cream Beclomethasone. The total quantity required across all items is 15570 units. Bids are to be submitted via the GEM portal, with the bidding period commencing on August 10, 2026, at 4:27 PM and concluding on August 31, 2026, at 5:00 PM. The contracting authority is located at 323307 Contracts & Material Management, RAPS Hospital, PO-Bhabha Nagar, Rawatbhata, Via-Kota, Rajasthan. This procurement falls under the purview of the Prime Minister's Office (PMO) as indicated by the Ministry/State Name.